aztreonam has been researched along with Experimental Radiation Injuries in 1 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with aztreonam reduced the incidence of mice infected with Proteus mirabilis (p < 0." | 1.29 | Prevention of radiation-induced bacteraemia by post-treatment with OK-432 and aztreonam. ( Kurishita, A; Ono, T; Uchida, A, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kurishita, A | 1 |
| Ono, T | 1 |
| Uchida, A | 1 |
1 other study available for aztreonam and Experimental Radiation Injuries
| Article | Year |
|---|---|
Prevention of radiation-induced bacteraemia by post-treatment with OK-432 and aztreonam.
Topics: Animals; Aztreonam; Bacteremia; Enterococcus faecalis; Mice; Picibanil; Proteus mirabilis; Radiation | 1993 |